Forest Pharmaceuticals Recalls Bystolic Tablets for Dissolution Failure
Forest Pharmaceuticals is recalling Bystolic (nebivolol) 20 mg tablets because they failed stage III dissolution testing. The recall affects 92,544 bottles distributed nationwide.
- Product
- Bystolic (nebivolol) tablets, 20 mg/tablet. 7 Tablet Professional Sample Bottle, Rx Only. Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, Missouri 63045. NDC 0456-1420-07.
- Category
- Drug
- Distribution
- Distributed nationwide